Gland Pharma shares will be in focus after promoter Fosun Pharma Industrial launched a block deal to sell a 5% stake at a floor price of Rs 2,763 per share. The company also recently reported strong Q1FY27 results and received zero Form 483 observations from the USFDA following an inspection of its Visakhapatnam facilities.
Market Samachar is a news aggregator. This article was originally published by Stocks-Markets-Economic Times. Tap the button above to read the full story on their site.